Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 12:22 PM
Ignite Modification Date:
2025-12-24 @ 12:22 PM
NCT ID:
NCT06116461
Eligibility Criteria:
Inclusion Criteria:
* Age ≥ 18 years
* Advanced or metastatic melanoma
* Current treatment with nivolumab for advanced or metastatic melanoma, in a 6 mg/kg or 480 mg, 4 weekly scheme
* Documented confirmed and ongoing CR, PR or SD according to RECIST v1.1
* On treatment for at least 6 months
Exclusion Criteria:
* Unable to draw blood for study purposes
* Patients willing to participate or already included in the SAFE-STOP trial
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06116461
Study Brief:
Protocol Section:
NCT06116461